Mercer Global Advisors Inc Charles River Laboratories International, Inc. Transaction History

Mercer Global Advisors Inc

$48.3 Billion
Q2 2025

A detailed history of Mercer Global Advisors Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 3,013 shares of CRL stock, worth $535,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,013

Previous 2,972 1.38%

Holding current value

$535,862

Previous $447,000 2.24%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$99.75 - $151.89 $4,089 - $6,227	41 Added 1.38%	3,013 $457,000
Q1 2025 May 15, 2025	BUY	$150.52 - $190.14 $78,420 - $99,062	521 Added 21.26%	2,972 $447,000
Q4 2024 Feb 14, 2025	SELL	$178.58 - $220.69 $340,552 - $420,855	-1,907 Reduced 43.76%	2,451 $452,000
Q3 2024 Nov 13, 2024	BUY	$187.96 - $245.29 $61,462 - $80,209	327 Added 8.11%	4,358 $858,000
Q2 2024 Aug 12, 2024	BUY	$206.39 - $268.73 $355,197 - $462,484	1,721 Added 74.5%	4,031 $832,000
Q1 2024 May 15, 2024	BUY	$203.52 - $273.43 $42,739 - $57,420	210 Added 10.0%	2,310 $626,000
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $23,526 - $34,154	143 Added 7.31%	2,100 $497,000
Q3 2023 Nov 13, 2023	BUY	$194.44 - $217.61 $55,804 - $62,454	287 Added 17.19%	1,957 $384,000
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $42,988 - $49,198	-234 Reduced 12.29%	1,670 $351,000
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $44,134 - $59,781	230 Added 13.74%	1,904 $384,000
Q4 2022 Feb 08, 2023	SELL	$197.11 - $250.07 $5,913 - $7,502	-30 Reduced 1.76%	1,674 $365,000
Q3 2022 Nov 15, 2022	SELL	$182.44 - $250.54 $14,047 - $19,291	-77 Reduced 4.32%	1,704 $335,000
Q2 2022 Aug 10, 2022	BUY	$204.13 - $302.4 $45,520 - $67,435	223 Added 14.31%	1,781 $381,000
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $318,876 - $451,913	-1,248 Reduced 44.48%	1,558 $442,000
Q4 2021 Feb 04, 2022	BUY	$351.38 - $448.68 $204,854 - $261,580	583 Added 26.23%	2,806 $1.06 Million
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $6,707 - $8,249	-18 Reduced 0.8%	2,223 $917,000
Q2 2021 Aug 10, 2021	BUY	$294.17 - $371.65 $436,842 - $551,900	1,485 Added 196.43%	2,241 $829,000
Q1 2021 May 11, 2021	BUY	$249.67 - $299.48 $188,750 - $226,406	756 New	756 $219,000

Others Institutions Holding CRL

# of Institutions

640

Shares Held

52.9M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.05B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Charles River Laboratories International, Inc. Transaction History